Leveraging decades of expertise in licensing and scale up, Purisys offers cannabinoid-focused companies a fully integrated supply chain for synthetic cannabinoid-based APIs.
Purisys has regulatory filings and the know-how to make dozens of APIs, and we offer a fully operational global supply chain, exporting to more than 40 countries – with full international regulatory compliance.
Our commitment to handling standards combines with our global logistical experience to offer a broad lineup of manufacturing and personnel assets for the development, manufacture, and support of cannabinoid-derived APIs.
Our flagship, 17,000-square-foot innovation center and manufacturing facility in Athens, Georgia, is staffed by teams with decades of experience in complex high-barrier custom synthetic chemistry and manufacture of cannabinoid-derived APIs.
Formed as a wholly owned subsidiary of Noramco, which began manufacturing commercial pharmaceutical ingredients in 1979, Purisys now has decades of experience in high-barrier, custom synthetic chemistry and the manufacture of commercial and clinical-stage pharmaceuticals. We combine our pedigree in custom synthesis and GMP manufacturing to provide customers with a high-quality, broad portfolio of API manufacturing and testing services.